DELC.C

Delic Holdings (DELC.C) announced today that it has completed the acquisition of Ketamine Infusion Centers (KIC). Currently, KIC owns and operated two ketamine infusion treatment clinics, one in Phoenix,…
Delic Corp (DELC.C) announced that their wholly-owned subsidiary, DELIC Labs, has entered into a partnership agreement with Agilent. Agilent provides laboratories worldwide with instruments, services, consumables, applications and expertise,…
Delic Holdings (DELC.C) announced they have signed a definitive agreement to acquire Ketamine Infusion Centers (KIC). Delic will acquire all of the issued and outstanding shares of KIC from…
Delic Holdings (DELC.C) announced that their acquisition target, Complex Biotech Discovery Venture (CBDV), has closed their previously-announced non-brokered private placement. Reade full article here: https://equity.guru/2021/05/17/delic-delc-c-acquisition-target-completes-3-43-million-private-placement/…
On May 27, Delic Holdings (DELC.C) announced they have acquired all of the issued and outstanding shares in the capital of Complex Biotech Discovery Ventures (CBDV), completing their acquisition…
Delic Holdings (DELC.C) announced that their acquisition target, Complex Biotech Discovery Venture (CBDV), has closed their previously-announced non-brokered private placement. The private placement consists of 11,441,189 CBDV Subscription Receipts…
Delic Holdings (DELC.C) announced that their acquisition target, Ketamine Infusion Centers (KIC), proposed an acquisition of two additional licensed ketamine clinics in Arizona. Back in February, Delic signed a…
At Equity.Guru, engaged as we are in market awareness programs for public companies, we often see competing entities that are more promotional than journalistic, banging out borderline insanity regarding…
Delic Holdings (DELC.C) announced that their acquisition target, Complex Biotech Discovery Ventures (CBDV), has hired Dr. Eric Janusson as their Lead Chemist. Dr. Eric Janusson is an analytical organometallic…
On February 5th, 2021 DELIC announced the acquisition of KIC, who over the last 3 years have overseen 4,000 ketamine infusion treatments, while revenues increase to over USD $1.5…